1 North Wealth Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

1 North Wealth Services’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.87K	Hold	85	–	–	﹤0.01%	268
2026 Q1	$2.47K	Hold	85	–	–	﹤0.01%	235
2025 Q4	$2.23K	Hold	85	–	–	﹤0.01%	246
2025 Q3	$2.01K	Hold	85	–	–	﹤0.01%	231
2025 Q2	$1.74K	Hold	85	–	–	﹤0.01%	239
2025 Q1	$1.74K	Buy	+85	New	+$1.9K	﹤0.01%	237

Other funds holding IDNA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

1 North Wealth Services's IDNA Position: Q2 2026 in Review

1 North Wealth Services held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q2 2026 at 85 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #268.

1 North Wealth Services first reported a position in IDNA in Q1 2025 and has held it in 6 quarters since. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

1 North Wealth Services held 85 shares of iShares Genomics Immunology and Healthcare ETF worth $2.87K as of Q2 2026.
1 North Wealth Services left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q2 2026.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of 1 North Wealth Services's portfolio in Q2 2026, its #268 holding.
1 North Wealth Services first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2025 and has held it in 6 quarters since.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on 1 North Wealth Services's 13F filing for Q2 2026, filed 3 Aug 2026.